NCT07071129

Virtual Reality for Enhancement of Vision

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 12 Years
• Healthy volunteers: Accepted

Summary

This project aims to evaluate the use of Virtual Reality (VR) based visual stimulation for the treatment of blindness arising from Glaucoma and other retinal diseases or disorders of the visual system, through regeneration of axons of retinal ganglion cells (RGCs) in humans. In certain cases of blindness, such as in Glaucoma, or in certain injuries, the optic nerves behind the retina of our eyes get damaged, leading to partial blindness, mostly near the periphery of our eye. Recent research in Dr.Huberman's laboratory has identified visual stimulation as a non-invasive model for regeneration of such damaged axons in rodents, back to the vision centers of their brain.

Conditions

• Glaucoma
• Vision Disorder

Interventions

Type	Name	Description
DEVICE	Virtual Reality Stimulation	VR 1 hour sessions will consist of an exposure to a non-invasive visual stimulation where the subject will be sitting wearing a VR headset.

Timeline

• Start date: 2018-04-17
• Primary completion: 2025-07-07
• Completion: 2025-09-07
• First posted: 2025-07-17
• Last updated: 2025-12-10
• Results posted: 2025-12-10

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study